SCHEMBL20159646

SCHEMBL20159646

COc1ccccc1N(c1ccc2c(c1)C(C)(C)c1ccccc1-2)c1ccc2c(c1)C1(c3cc(N(c4ccc5c(c4)C(C)(C)c4ccccc4-5)c4ccccc4OC)ccc3-2)c2cc(N(c3ccc4c(c3)C(C)(C)c3ccccc3-4)c3ccccc3OC)ccc2-c2ccc(N(c3ccc4c(c3)C(C)(C)c3ccccc3-4)c3ccccc3OC)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 6/20 0.37
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
MDM2 Q00987 1/20 0.32
HTR7 P34969 2/20 0.32
PTPRC P08575 1/20 0.31
PTPN1 P18031 1/20 0.31
PAX8 Q06710 1/20 0.31
TLR9 Q9NR96 1/20 0.31
ADRA2B P18089 2/20 0.31
ADRA1A P35348 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
MLNR O43193 1/20 0.31
NR1I2 O75469 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201848 0.85 PTGES (0.41) PDK2ALDH1A1SMN1; SMN2HPGDALOX15
SCHEMBL24751092 0.83 PDK2 (0.41) PDK2SMN1; SMN2KDM4ELMNAADRA2B
SCHEMBL10038928 0.83 PDK2 (0.41) PDK2SMN1; SMN2KDM4ELMNAADRA2B
SCHEMBL15183770 0.83 PDK2 (0.41) PDK2SMN1; SMN2KDM4ELMNAADRA2B
SCHEMBL20159639 0.83 PGR (0.41) PDK2SMN1; SMN2HPGDALOX15PGR
SCHEMBL21559315 0.82 PDK2 (0.40) PDK2SMN1; SMN2KDM4ELMNAADRA2B
SCHEMBL24904692 0.82 PDK2 (0.40) PDK2SMN1; SMN2KDM4ELMNAADRA2B
SCHEMBL17816806 0.82 PDK2 (0.40) PDK2SMN1; SMN2KDM4ELMNAADRA2B
SCHEMBL17816604 0.82 PDK2 (0.40) PDK2SMN1; SMN2KDM4ELMNAADRA2B
SCHEMBL16996394 0.82 PGR (0.40) PDK2SMN1; SMN2HPGDALOX15PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11563180-B2 Spirobifluorene compound and perovskite solar cell comprising same KOREA RESEARCH INSTITUTE OF CHECMICAL TECHNOLOGY (KR) 2023-01-24 US disclosed
US-20190288207-A1 SPIROBIFLUORENE COMPOUND AND PEROVSKITE SOLAR CELL COMPRISING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2019-09-19 US disclosed
WO-2018088797-A1 SPIROBIFLUORENE COMPOUND AND PEROVSKITE SOLAR CELL COMPRISING SAME 한국화학연구원 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11563180-B2 Spirobifluorene compound and perovskite solar cell comprising same SLC9B2, STOM, SLC46A1 PDK2 332/4885ALDH1A1 1694/4885SMN1; SMN2 3383/4885
US-20190288207-A1 SPIROBIFLUORENE COMPOUND AND PEROVSKITE SOLAR CELL COMPRISING SAME SLC9B2, STOM, SLC46A1 PDK2 332/4885ALDH1A1 1694/4885SMN1; SMN2 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.